Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -686.66%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-478.32%
RETURN ON EQUITY (ROE) AVG 3Y
-453.69%
RETURN ON EQUITY (ROE) AVG 5Y
-330.22%
RETURN ON EQUITY (ROE) AVG 10Y
-218.38%
RETURN ON EQUITY (ROE) AVG 15Y
-118.57%
RETURN ON EQUITY (ROE) AVG 20Y
-53.69%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Alphatec Holdings, Inc.
Market Cap
$1.65B
Return on Equity (ROE)
N/A
TTM Avg
-478.32%
3Y Avg
-453.69%
5Y Avg
-330.22%
Market Cap
$1.65B
Return on Equity (ROE)
17.72%
TTM Avg
5.08%
3Y Avg
0.03%
5Y Avg
-3.88%
Market Cap
$1.71B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$1.57B
Return on Equity (ROE)
-7.08%
TTM Avg
-0.64%
3Y Avg
-1.30%
5Y Avg
-2.08%
Market Cap
$1.76B
Return on Equity (ROE)
15.35%
TTM Avg
-64.31%
3Y Avg
-71.44%
5Y Avg
-70.74%
Market Cap
$1.52B
Return on Equity (ROE)
27.24%
TTM Avg
-16.62%
3Y Avg
-27.07%
5Y Avg
-49.65%
Market Cap
$1.52B
Return on Equity (ROE)
-17.32%
TTM Avg
-19.51%
3Y Avg
-16.07%
5Y Avg
-12.58%
Market Cap
$1.78B
Return on Equity (ROE)
-54.96%
TTM Avg
-60.50%
3Y Avg
-51.30%
5Y Avg
-42.73%
Market Cap
$1.78B
Return on Equity (ROE)
N/A
TTM Avg
36.48%
3Y Avg
36.48%
5Y Avg
36.48%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.65B | N/A | -478.32% | -453.69% | -330.22% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 17.72% | 5.08% | 0.03% | -3.88% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -40.41% | -45.75% | -30.11% | -18.95% |
| Certara, Inc. (CERT)vs › | $1.57B | -7.08% | -0.64% | -1.30% | -2.08% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 15.35% | -64.31% | -71.44% | -70.74% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 27.24% | -16.62% | -27.07% | -49.65% |
| GH Research PLC (GHRS)vs › | $1.52B | -17.32% | -19.51% | -16.07% | -12.58% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -54.96% | -60.50% | -51.30% | -42.73% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | N/A | 36.48% | 36.48% | 36.48% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
ROE
N/A
ROA
-13.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -686.66% |
| 2025-12-31 | -397.90% |
| 2025-06-30 | -350.40% |
| 2024-09-30 | -799.73% |
| 2024-06-30 | -444.34% |
| 2024-03-31 | -313.31% |
| 2023-12-31 | -183.48% |
| 2022-06-30 | -478.54% |
| 2022-03-31 | -250.46% |
| 2021-12-31 | -181.72% |
| 2021-09-30 | -96.23% |
| 2021-06-30 | -48.51% |
| 2021-03-31 | -61.55% |
| 2020-12-31 | -50.16% |
| 2020-09-30 | -188.87% |
| 2020-06-30 | -143.65% |
| 2020-03-31 | -236.08% |
| 2019-12-31 | -78.91% |
| 2019-09-30 | -87.76% |
| 2019-06-30 | -320.51% |
| 2019-03-31 | -432.72% |
| 2018-12-31 | -164.87% |
| 2018-09-30 | -38.38% |
| 2018-06-30 | -10.17% |
| 2018-03-31 | 4.13% |
| 2015-06-30 | -8.85% |
| 2015-03-31 | -8.01% |
| 2014-12-31 | -8.65% |
| 2014-09-30 | -47.62% |
| 2014-06-30 | -51.56% |
| 2014-03-31 | -51.92% |
| 2013-12-31 | -47.90% |
| 2013-09-30 | -11.87% |
| 2013-06-30 | -6.36% |
| 2013-03-31 | -7.02% |
| 2012-12-31 | -6.29% |
| 2012-09-30 | -10.95% |
| 2012-06-30 | -10.61% |
| 2012-03-31 | -8.67% |
| 2011-12-31 | -9.04% |
| 2011-09-30 | -3.40% |
| 2011-06-30 | -4.20% |
| 2011-03-31 | -4.18% |
| 2010-12-31 | -5.39% |
| 2010-09-30 | -4.76% |
| 2010-06-30 | -4.00% |
| 2010-03-31 | -5.92% |
| 2009-12-31 | -17.76% |
| 2009-09-30 | -22.63% |
| 2009-06-30 | -28.25% |
| 2009-03-31 | -26.49% |
| 2008-12-31 | -40.98% |
| 2008-09-30 | -47.74% |
| 2008-06-30 | -46.12% |
| 2008-03-31 | -40.65% |
| 2007-12-31 | -21.30% |
| 2007-09-30 | -19.20% |
| 2007-06-30 | -26.51% |
| 2007-03-31 | -30.70% |
| 2006-12-31 | -34.42% |
| 2006-09-30 | -21.42% |
| 2006-06-30 | -17.71% |
| 2004-12-31 | 27.87% |
